Public-registry site landscape for NCT03104270, a Multiple Myeloma study sponsored by Oncotherapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03104270 (registry record) |
| Sponsor | Oncotherapeutics |
| Condition(s) | Multiple Myeloma |
| Phase | PHASE2 |
| Listed sites | 6 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03104270 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →